Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus

Serena Low,Kiat Sern Goh,Tze Pin Ng,Angela Moh,Su Fen Ang,Jonathon Khoo,Keven Ang,Philip Yap,Chin Yee Cheong,Wern Ee Tang,Ziliang Lim,Tavintharan Subramaniam,Chee Fang Sum,Su Chi Lim
DOI: https://doi.org/10.1016/j.jdiacomp.2022.108258
IF: 3.219
2022-09-01
Journal of Diabetes and its Complications
Abstract:AimsTo examine the longitudinal association between skeletal muscle mass (SMM) loss and cognitive decline over time in type 2 diabetes mellitus (T2DM).MethodsWe conducted a prospective cohort study of 453 patients from SMART2D cohort with follow-up intervals of 1.6 to 6.4 years. Baseline and follow-up measurements included bio-impedance analysis (BIA) measure of skeletal muscle mass index (SMI) and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) measure of cognitive function. We examined the association between annual rate of SMI and RBANS scores using linear regression, adjusting for demographics, education, depression, clinical co-variables and presence of apolipoprotein E4 (APOE) Ɛ4 allele.ResultsThe mean age of participants was 60.3 ± 7.4 years. Compared to patients with Tertile 1 SMI change, the group with greater SMI decline (Tertile 3 SMI change) experienced 0.30 decline in RBANS total score (95%CI −0.57 to −0.03; p = 0.030) in the adjusted analysis. RBANS scores for subdomains in immediate memory and visuo-spatial/construction were lower in Tertile 3 SMI change group with corresponding coefficients −0.54 (95%CI −1.01 to −0.06; p = 0.026), and −0.71 (95%CI −1.30 to −0.12; p = 0.019) respectively.ConclusionIn patients with T2DM, BIA measure of muscle mass loss over time was independently associated with cognitive decline globally and in the domains of memory and visuo-spatial/construction.
endocrinology & metabolism
What problem does this paper attempt to address?